$NYMX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NYMOX PHARMACEUTICAL CORP. Get notifications about new insider transactions in NYMOX PHARMACEUTICAL CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.38 | 2,490 | 5,926 | 2,779,540 | 2.8 M to 2.8 M (+0.09 %) |
May 06 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.35 | 4,500 | 10,575 | 2,777,050 | 2.8 M to 2.8 M (+0.16 %) |
Apr 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.44 | 3,500 | 8,540 | 2,718,050 | 2.7 M to 2.7 M (+0.13 %) |
Apr 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.40 | 4,500 | 10,800 | 2,714,550 | 2.7 M to 2.7 M (+0.17 %) |
Apr 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.44 | 4,500 | 10,980 | 2,710,050 | 2.7 M to 2.7 M (+0.17 %) |
Apr 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.45 | 4,500 | 11,025 | 2,705,550 | 2.7 M to 2.7 M (+0.17 %) |
Apr 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.27 | 3,500 | 7,945 | 2,701,050 | 2.7 M to 2.7 M (+0.13 %) |
Apr 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.31 | 1,283 | 2,964 | 2,772,550 | 2.8 M to 2.8 M (+0.05 %) |
Apr 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.31 | 4,500 | 10,395 | 2,771,267 | 2.8 M to 2.8 M (+0.16 %) |
Apr 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.24 | 4,217 | 9,446 | 2,766,767 | 2.8 M to 2.8 M (+0.15 %) |
Apr 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.24 | 5,000 | 11,200 | 2,762,550 | 2.8 M to 2.8 M (+0.18 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.21 | 5,000 | 11,050 | 2,697,550 | 2.7 M to 2.7 M (+0.19 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.19 | 3,500 | 7,665 | 2,692,550 | 2.7 M to 2.7 M (+0.13 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.23 | 4,500 | 10,035 | 2,689,050 | 2.7 M to 2.7 M (+0.17 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.34 | 4,500 | 10,530 | 2,684,550 | 2.7 M to 2.7 M (+0.17 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.31 | 3,500 | 8,085 | 2,680,050 | 2.7 M to 2.7 M (+0.13 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.38 | 3,500 | 8,330 | 2,676,550 | 2.7 M to 2.7 M (+0.13 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.34 | 2,500 | 5,850 | 2,673,050 | 2.7 M to 2.7 M (+0.09 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.29 | 3,500 | 8,015 | 2,670,550 | 2.7 M to 2.7 M (+0.13 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.29 | 2,500 | 5,725 | 2,667,050 | 2.7 M to 2.7 M (+0.09 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.30 | 2,500 | 5,750 | 2,664,550 | 2.7 M to 2.7 M (+0.09 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.28 | 2,000 | 4,560 | 2,662,050 | 2.7 M to 2.7 M (+0.08 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.34 | 1,000 | 2,340 | 2,660,050 | 2.7 M to 2.7 M (+0.04 %) |
Mar 25 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.31 | 1,500 | 3,465 | 2,659,050 | 2.7 M to 2.7 M (+0.06 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.39 | 3,500 | 8,365 | 2,757,550 | 2.8 M to 2.8 M (+0.13 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.37 | 3,000 | 7,110 | 2,754,050 | 2.8 M to 2.8 M (+0.11 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.39 | 3,500 | 8,365 | 2,751,050 | 2.7 M to 2.8 M (+0.13 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.19 | 5,000 | 10,950 | 2,747,550 | 2.7 M to 2.7 M (+0.18 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.32 | 5,000 | 11,600 | 2,742,550 | 2.7 M to 2.7 M (+0.18 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.40 | 3,000 | 7,200 | 2,737,550 | 2.7 M to 2.7 M (+0.11 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.45 | 3,000 | 7,350 | 2,734,550 | 2.7 M to 2.7 M (+0.11 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.45 | 4,500 | 11,025 | 2,731,550 | 2.7 M to 2.7 M (+0.17 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.49 | 4,500 | 11,205 | 2,727,050 | 2.7 M to 2.7 M (+0.17 %) |
Apr 15 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.53 | 4,500 | 11,385 | 2,722,550 | 2.7 M to 2.7 M (+0.17 %) |
Jan 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.48 | 10,000 | 24,800 | 2,657,550 | 2.6 M to 2.7 M (+0.38 %) |
Jan 13 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.40 | 10,000 | 24,000 | 2,647,550 | 2.6 M to 2.6 M (+0.38 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.71 | 10,000 | 27,100 | 2,637,550 | 2.6 M to 2.6 M (+0.38 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.57 | 10,000 | 25,700 | 2,627,550 | 2.6 M to 2.6 M (+0.38 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.60 | 10,000 | 26,000 | 2,617,550 | 2.6 M to 2.6 M (+0.38 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.84 | 10,650 | 30,246 | 2,607,550 | 2.6 M to 2.6 M (+0.41 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.91 | 10,000 | 29,100 | 2,596,900 | 2.6 M to 2.6 M (+0.39 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.99 | 10,000 | 29,900 | 2,586,900 | 2.6 M to 2.6 M (+0.39 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.08 | 9,350 | 28,798 | 2,576,900 | 2.6 M to 2.6 M (+0.36 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.21 | 10,000 | 32,100 | 2,567,550 | 2.6 M to 2.6 M (+0.39 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.07 | 6,417 | 19,700 | 2,557,550 | 2.6 M to 2.6 M (+0.25 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.07 | 3,583 | 11,000 | 2,551,133 | 2.5 M to 2.6 M (+0.14 %) |
Jan 08 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.11 | 5,000 | 15,550 | 2,547,550 | 2.5 M to 2.5 M (+0.20 %) |
Dec 30 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.38 | 5,000 | 16,900 | 2,542,550 | 2.5 M to 2.5 M (+0.20 %) |
Dec 30 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.55 | 14,000 | 49,700 | 2,537,550 | 2.5 M to 2.5 M (+0.55 %) |
Dec 30 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.79 | 6,000 | 22,740 | 2,523,550 | 2.5 M to 2.5 M (+0.24 %) |
Dec 24 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.46 | 9,210 | 31,867 | 2,517,550 | 2.5 M to 2.5 M (+0.37 %) |
Dec 24 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.37 | 9,944 | 33,511 | 2,508,340 | 2.5 M to 2.5 M (+0.40 %) |
Dec 24 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.51 | 700 | 2,457 | 2,498,396 | 2.5 M to 2.5 M (+0.03 %) |
Dec 24 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.77 | 10,000 | 37,700 | 2,497,696 | 2.5 M to 2.5 M (+0.40 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.68 | 10,000 | 36,800 | 2,487,696 | 2.5 M to 2.5 M (+0.40 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.95 | 100 | 395 | 2,477,696 | 2.5 M to 2.5 M (0.00 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.96 | 1,300 | 5,148 | 2,477,596 | 2.5 M to 2.5 M (+0.05 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.97 | 8,600 | 34,142 | 2,476,296 | 2.5 M to 2.5 M (+0.35 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.46 | 200 | 692 | 2,467,696 | 2.5 M to 2.5 M (+0.01 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.43 | 10,000 | 34,300 | 2,467,496 | 2.5 M to 2.5 M (+0.41 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.40 | 9,946 | 33,816 | 2,457,496 | 2.4 M to 2.5 M (+0.41 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.42 | 10,000 | 34,200 | 2,447,550 | 2.4 M to 2.4 M (+0.41 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.47 | 10,000 | 34,700 | 2,437,550 | 2.4 M to 2.4 M (+0.41 %) |
Dec 18 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.53 | 3,188 | 11,254 | 2,427,550 | 2.4 M to 2.4 M (+0.13 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.53 | 7,334 | 25,889 | 2,424,362 | 2.4 M to 2.4 M (+0.30 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.07 | 7,000 | 28,490 | 2,417,028 | 2.4 M to 2.4 M (+0.29 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.61 | 10,000 | 36,100 | 2,410,028 | 2.4 M to 2.4 M (+0.42 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 2,478 | 8,177 | 2,400,028 | 2.4 M to 2.4 M (+0.10 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 10,000 | 32,700 | 2,397,550 | 2.4 M to 2.4 M (+0.42 %) |
Dec 11 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 10,000 | 33,100 | 2,387,550 | 2.4 M to 2.4 M (+0.42 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.49 | 10,000 | 34,900 | 2,377,550 | 2.4 M to 2.4 M (+0.42 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.53 | 10,000 | 35,300 | 2,367,550 | 2.4 M to 2.4 M (+0.42 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.55 | 10,000 | 35,500 | 2,357,550 | 2.3 M to 2.4 M (+0.43 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.61 | 9,410 | 33,970 | 2,347,550 | 2.3 M to 2.3 M (+0.40 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.46 | 10,000 | 34,600 | 2,338,140 | 2.3 M to 2.3 M (+0.43 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.63 | 10,000 | 36,300 | 2,328,140 | 2.3 M to 2.3 M (+0.43 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.40 | 590 | 2,006 | 2,318,140 | 2.3 M to 2.3 M (+0.03 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 10,000 | 33,300 | 2,317,550 | 2.3 M to 2.3 M (+0.43 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 10,000 | 33,100 | 2,307,550 | 2.3 M to 2.3 M (+0.44 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 7,100 | 23,785 | 2,297,550 | 2.3 M to 2.3 M (+0.31 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.36 | 9,500 | 31,920 | 2,290,450 | 2.3 M to 2.3 M (+0.42 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 848 | 2,790 | 2,280,950 | 2.3 M to 2.3 M (+0.04 %) |
Dec 04 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 12,552 | 41,171 | 2,280,102 | 2.3 M to 2.3 M (+0.55 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.44 | 16,400 | 40,016 | 2,267,550 | 2.3 M to 2.3 M (+0.73 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.45 | 10,000 | 24,500 | 2,251,150 | 2.2 M to 2.3 M (+0.45 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.38 | 4,100 | 9,758 | 2,241,150 | 2.2 M to 2.2 M (+0.18 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.34 | 9,500 | 22,230 | 2,237,050 | 2.2 M to 2.2 M (+0.43 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.21 | 10,000 | 22,100 | 2,227,550 | 2.2 M to 2.2 M (+0.45 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.11 | 10,000 | 21,100 | 2,217,550 | 2.2 M to 2.2 M (+0.45 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.05 | 10,000 | 20,500 | 2,207,550 | 2.2 M to 2.2 M (+0.46 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.15 | 10,000 | 21,500 | 2,197,550 | 2.2 M to 2.2 M (+0.46 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.10 | 10,000 | 21,000 | 2,187,550 | 2.2 M to 2.2 M (+0.46 %) |
Sep 08 2015 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.19 | 10,000 | 21,900 | 2,177,550 | 2.2 M to 2.2 M (+0.46 %) |